Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features
- PMID: 10825360
- DOI: 10.1093/brain/123.6.1229
Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features
Abstract
The cluster in Jews of Libyan origin of limb-girdle muscular dystrophy type 2B due to a dysferlin 1624delG mutation is described. The carrier frequency of this mutation is calculated to be approximately 10% in this population, in which the disease prevalence is at least 1 per 1300 adults. Twenty-nine patients from 12 families were all homozygous for the same mutation. However, clinical features were heterogeneous even within the same family: in half of the patients onset was in the distal muscles of the legs, which is similar to Miyoshi myopathy, while in others onset was in the proximal musculature, which is similar to other forms of limb-girdle dystrophies. Age at onset varied from 12 to 28 years (mean 20.3 +/- 5.5 years). One patient was presymptomatic at age 28 years. Progression was slow regardless of age of onset, patients remaining ambulatory until at least 33 years. Five patients described subacute, painful enlarged calves as an early, unusual feature. The variable features in this ethnic cluster contribute to the definition of the clinical spectrum of dysferlinopathies in general. The cause of the observed heterogeneity remains unclear.
Similar articles
-
A new dysferlin gene mutation in two Japanese families with limb-girdle muscular dystrophy 2B and Miyoshi myopathy.Neuromuscul Disord. 2001 Mar;11(2):139-45. doi: 10.1016/s0960-8966(00)00168-1. Neuromuscul Disord. 2001. PMID: 11257469
-
Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy.Neurology. 2000 Dec 26;55(12):1931-3. doi: 10.1212/wnl.55.12.1931. Neurology. 2000. PMID: 11134403
-
Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).Hum Mol Genet. 1999 May;8(5):871-7. doi: 10.1093/hmg/8.5.871. Hum Mol Genet. 1999. PMID: 10196377
-
Dysferlin and the plasma membrane repair in muscular dystrophy.Trends Cell Biol. 2004 Apr;14(4):206-13. doi: 10.1016/j.tcb.2004.03.001. Trends Cell Biol. 2004. PMID: 15066638 Review.
-
Translational research and therapeutic perspectives in dysferlinopathies.Mol Med. 2011 Sep-Oct;17(9-10):875-82. doi: 10.2119/molmed.2011.00084. Epub 2011 May 6. Mol Med. 2011. PMID: 21556485 Free PMC article. Review.
Cited by
-
Treatment with galectin-1 improves myogenic potential and membrane repair in dysferlin-deficient models.PLoS One. 2020 Sep 3;15(9):e0238441. doi: 10.1371/journal.pone.0238441. eCollection 2020. PLoS One. 2020. PMID: 32881965 Free PMC article.
-
Therapeutic possibilities in the autosomal recessive limb-girdle muscular dystrophies.Neurotherapeutics. 2008 Oct;5(4):619-26. doi: 10.1016/j.nurt.2008.08.003. Neurotherapeutics. 2008. PMID: 19019315 Free PMC article. Review.
-
Dysferlinopathy course and sportive activity: clues for possible treatment.Acta Myol. 2011 Oct;30(2):127-32. Acta Myol. 2011. PMID: 22106716 Free PMC article.
-
Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):433-40. doi: 10.1136/jnnp-2011-301339. Epub 2012 Dec 15. J Neurol Neurosurg Psychiatry. 2013. PMID: 23243261 Free PMC article.
-
Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia.Front Neurosci. 2022 Feb 22;16:815556. doi: 10.3389/fnins.2022.815556. eCollection 2022. Front Neurosci. 2022. PMID: 35273475 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical